Suggestions
Yelak Biru, MSc
President and Chief Executive Officer at International Myeloma Foundation | Cancer Research Advocate | Myeloma Patient
Yelak Biru, MSc, serves as the President and Chief Executive Officer of the International Myeloma Foundation (IMF). His leadership is characterized by a strong commitment to advancing myeloma research, patient advocacy, and community engagement.
Professional Background
Biru's professional journey is marked by resilience and strategic vision, particularly in the context of myeloma awareness and support for patients. He has been actively involved in various initiatives aimed at improving outcomes for myeloma patients, including organizing significant events such as the International Myeloma Foundation Gala, which focuses on raising awareness and funds for myeloma research and support services.12
Education and Advocacy
He holds a Master of Science degree and is recognized not only for his leadership at the IMF but also for his personal experience as a myeloma patient. His unique perspective as both a leader and a patient informs his advocacy work, allowing him to connect deeply with those affected by the disease.14
Biru's contributions extend to discussions on clinical outcomes and patient advocacy, highlighting the importance of patient-centered approaches in cancer research and treatment.34
Highlights
On Thursday we launched our inagural 5-night, 6-day Iceland Cycling Expedition (#MyelomaICE)!
Our journey began with a visit to deCODE genetics headquarters and the #iStopMM (Iceland Screens, Treats or Stops Myeloma Study) laboratories. Launched in 2016, iStopMM is a population-based screening study for early detection and intervention of myeloma.
This groundbreaking study boasts the highest participation rate of any clinical trial in a single nation! With over 80,000 individuals (54.2% of Iceland's population over 40) consenting to be screened, iStopMM is paving the way for advancements in early detection and treatment of myeloma.
International Myeloma Foundation (IMF) is proud to be a seed and ongoing funder of this vital research.**
#Myeloma #MyelomaAwareness #iStopMM #ClinicalTrials #Research**
**A special thanks to our host, Dr. Sigurdur Yngvi Kristinsson
** Stay connected with the IMF and follow the brave participants: Joseph Mikhael Saad Z. Usmani Rafat Abonour Jered Haddad Leo J. Dierckman Sylvia Dsouza, MPA Andy Kuzneski III Laurie Kuzneski ...
#HelloMyelo COMING SOON: Myelo, the first myeloma-specific AI Assistant will be here to support patients on their #myeloma journey. #HelloMyelo
